CEO, Magellan Rx
Mostafa Kamal is the CEO of Magellan Rx (MRx), a separate business unit under Prime Therapeutics, and serves on Prime’s executive leadership team. In this role, Kamal leads MRx and is accountable for the Specialty and State Government Solutions business units.
Previously, Kamal was senior vice president and general manager of Magellan Rx Management’s specialty pharmacy business. In this role, he led sales, account management, operations and product development across the division, delivering industry-leading strategies and solutions to help clients successfully manage complex specialty pharmaceuticals in one of the fastest growing areas of health care spending. As chief underwriting officer, he directed the organization’s overall pricing and risk management strategies, and served as vice president of pricing, underwriting and analytics, where he developed financial strategies to help clients manage their pharmacy spend.
Before joining Magellan, Kamal held various roles with Medco Health Solutions, Inc., with responsibility for pricing, underwriting, strategy and Medicare Part D products and services. Additionally, he worked with clients to develop strategies to address healthcare reform and associated product offerings to ensure clients were successfully positioned in the post-healthcare reform era.
Kamal received his bachelor’s degree in economics from Rutgers University in New Brunswick, New Jersey.